Immunovia AB (publ) (STO:IMMNOV)
Sweden
· Delayed Price · Currency is SEK 0.2660
-0.0040 (-1.48%)
Apr 24, 2025, 5:29 PM CET
Immunovia AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 0.93 | 1.58 | 1.15 | 0.84 | 0.36 | Upgrade
|
| Revenue | 0.93 | 1.58 | 1.15 | 0.84 | 0.36 | Upgrade
|
| Revenue Growth (YoY) | -40.89% | 37.55% | 35.66% | 133.15% | 1.69% | Upgrade
|
| Cost of Revenue | - | 6.68 | 4.21 | -14.97 | -40.02 | Upgrade
|
| Gross Profit | 0.93 | -5.11 | -3.07 | 15.81 | 40.38 | Upgrade
|
| Selling, General & Admin | 94.48 | 148.3 | 162.97 | 162.09 | 165.12 | Upgrade
|
| Other Operating Expenses | 3.21 | 1.56 | 0.26 | 1.4 | 0.18 | Upgrade
|
| Operating Expenses | 111.11 | 291.58 | 188.14 | 182.55 | 175.06 | Upgrade
|
| Operating Income | -110.17 | -296.69 | -191.21 | -166.74 | -134.68 | Upgrade
|
| Interest Expense | -1.86 | -1.17 | -1.6 | -1.43 | -1.42 | Upgrade
|
| Interest & Investment Income | 34.73 | 6.28 | 0.75 | 0.71 | 0.58 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.76 | -17.87 | 23.97 | 11.5 | -10.51 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.01 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -76.54 | -309.44 | -168.09 | -155.97 | -146.03 | Upgrade
|
| Pretax Income | -76.54 | -309.44 | -168.09 | -155.97 | -146.03 | Upgrade
|
| Net Income | -76.54 | -309.44 | -168.09 | -155.97 | -146.03 | Upgrade
|
| Net Income to Common | -76.54 | -309.44 | -168.09 | -155.97 | -146.03 | Upgrade
|
| Shares Outstanding (Basic) | 83 | 39 | 23 | 23 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 83 | 39 | 23 | 23 | 21 | Upgrade
|
| Shares Change (YoY) | 112.20% | 72.02% | - | 6.05% | 9.05% | Upgrade
|
| EPS (Basic) | -0.93 | -7.95 | -7.43 | -6.89 | -6.84 | Upgrade
|
| EPS (Diluted) | -0.93 | -7.95 | -7.43 | -6.89 | -6.84 | Upgrade
|
| Free Cash Flow | -96.75 | -147.06 | -176.84 | -155.75 | -124.7 | Upgrade
|
| Free Cash Flow Per Share | -1.17 | -3.78 | -7.81 | -6.88 | -5.84 | Upgrade
|
| Gross Margin | 100.00% | - | -267.77% | 1873.58% | 11155.25% | Upgrade
|
| Operating Margin | -11833.94% | -18837.27% | -16699.48% | -19756.04% | -37203.87% | Upgrade
|
| Profit Margin | -8221.38% | -19646.92% | -14680.52% | -18479.38% | -40340.61% | Upgrade
|
| Free Cash Flow Margin | -10392.37% | -9336.95% | -15444.37% | -18453.67% | -34448.07% | Upgrade
|
| EBITDA | -96.42 | -170.03 | -185.15 | -161.1 | -130.41 | Upgrade
|
| D&A For EBITDA | 13.75 | 126.66 | 6.06 | 5.64 | 4.27 | Upgrade
|
| EBIT | -110.17 | -296.69 | -191.21 | -166.74 | -134.68 | Upgrade
|
| Revenue as Reported | 1.69 | 1.8 | 1.2 | 0.96 | 0.99 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.